Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

This narrative review found that Telogen Effluvium significantly affects women in Brazil due to its psychological impact and limited access to treatment, exacerbated by economic and healthcare disparities.

This article discusses telogen effluvium, a condition where a large number of scalp hairs prematurely enter the shedding phase, and reports no new clinical results; the authors emphasize the range of potential underlying causes.

This study found that there is substantial variability in laboratory testing practices among dermatologists specializing in alopecia areata across the globe, indicating the need for renewed discussions around guidelines for such testing.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

Some patients experience temporary hair loss after ulcerative colitis surgery, likely due to illness rather than the surgery itself, and it usually grows back within six months.

This case study describes hair loss as a potential late complication of multisystem inflammatory syndrome in children, observed in a 7-year-old girl who developed Telogen effluvium 73 days post-diagnosis.

This letter argues that the association between fluconazole therapy and alopecia may be misattributed, suggesting instead that systemic fungal infections themselves could lead to hair loss.

In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.

This study identified that certain diseases, including AIDS and systemic lupus erythematosus, may cause African hair to change to a silky, wavy texture similar to neonatal hair in affected patients.

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

This case report describes a patient with systemic lupus erythematosus who developed leukocytoclastic vasculitis, suggesting this skin condition may be related to SLE exacerbation.

This study chronicles a 4-year visual documentation of living with Systemic Lupus Erythematosus, highlighting the disease's progression and emphasizing early diagnosis and patient advocacy.

This case study reports the rare occurrence of widespread soft-tissue calcification in a young patient with SLE, suggesting that 99mTe-phosphate compounds could help diagnose this complication.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

This study developed the CATNIP computational model, which uses biological and chemical information to successfully identify drug repurposing opportunities for various conditions, including Parkinson’s disease and Type 2 Diabetes.

In this study, researchers found that adult tinea capitis in Korea shows unique epidemiological and clinical features compared to children, which may lead to misdiagnosis or delayed diagnosis.

This consensus statement outlines a treatment algorithm for alopecia areata, discussing when to consider systemic treatment and how to assess outcomes, without providing new clinical results.

This article narrates the author's personal journey with systemic lupus erythematosus over 15 years, highlighting the challenges and strategies for managing this complex disease and maintaining quality of life.

This case report describes a patient with unrecognized systemic lupus erythematosus, who experienced myocarditis, polyneuropathy, and pericarditis, and recovered following cardiac support and medication.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

This study reports previously unreported nail features in Cronkhite-Canada syndrome, specifically recurrent onychomadesis of all 20 nails linked to systemic illness.

This study found that androgenetic alopecia in men was significantly associated with dyslipidemia, particularly in more severe cases, suggesting it could be a marker for systemic illness.

This review characterizes breast implant illness and its autoimmune symptoms, reporting an association between breast implants and autoimmune diseases, with explantation relieving symptoms in over half of patients.

This study highlights that the skin can serve as a marker for systemic health during COVID-19 by showing symptoms like rashes and pigmentary changes, while also emphasizing dermatologists' key role in diagnosing COVID-induced and vaccine-related skin issues to enhance patient care and address vaccine hesitancy.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

This letter challenges Dr. Dubois' statement that nearly all patients with Raynaud phenomenon will develop a systemic disorder, arguing that many experience it without progressing to serious disease.

This study examines how the Severity of Alopecia Tool score was used to assess Alopecia Areata in patients while excluding systemic conditions that might affect vitamin D levels, but reports no new clinical results.

This study observed that patients with alopecia areata in the U.S. have a higher prevalence of several chronic illnesses, including essential hypertension, compared to controls.

This case report highlights that a patient who recovered from Covid-19 experienced Beau's Lines and temporary hair loss, indicating the lasting impact of the illness on nail and hair growth.